SESSION I - RECENT ADVANCES IN HEMATOLOGIC RESEARCH AND QUALITY OF LIFE (QoL)
Chairpersons: F. Pane (Napoli), A.M. Vannucchi (Firenze), A. Venditti (Roma)
Treatment advances for patients with myelofibrosis (MF) and value of patient-reported symptoms
C. Harrison (London, UK)Treatment tolerability and quality of life in patients with multiple myeloma (MM)
J.D. Peipert (Birmingham, UK)The value of quality of life data in MDS and AML to boost clinical research
F. Efficace (Roma)SESSION II - PATIENT ORGANIZATIONS AND EARLY PALLIATIVE CARE IN HEMATOLOGIC RESEARCH
Chairpersons: G. Caocci (Cagliari), M. Luppi (Modena)
The value of integrating early palliative care to improve patient outcomes
L. Potenza (Modena)SESSION III - DIGITAL HEALTH TOOLS AND ARTIFICIAL INTELLIGENCE (AI) IN HEMATOLOGY
Chairpersons: M.G. Della Porta (Rozzano-MI), A. Piciocchi (Roma), M.T. Voso (Roma)